Despite a decrease in pneumonia-related mortality in the United States between 1999 and 2022, significant differences in AAMR have been observed...
https://t.co/HBS0XYSfln
CAR-T cell therapy as a second line treatment appears to be effective in achieving higher response rates and delaying the disease progression compared to SOC in relapsing/remitting DLBCL https://t.co/uCm1lBCpAI
Recent interesting case report I had on my internal medicine rotation,
Enterohemorrhagic Escherichia coli: trigger for small vessel vasculitis https://t.co/2CbUAqohtU
Improving AAA Screening Rates in a US-Mexico Border Academic Clinic @hvpaa Architecture of HVC on 10/8: “Goal of the project was to improve AAA screening rates in an academic internal medicine clinic along the US-Mexico border by education both patients and resident physicians”
How to do “more with less” for transfusions @hvpaa Architecture of HVC Dr @stevefrank37 will present on methods of improving blood utilization by reducing unnecessary blood use. Blood saves lives when you need it, but increases risks and costs when you don’t 🩸
Come to listen to Dr. @zilbermint discuss how to define your innovative diabetes idea and formulate the plan to demonstrate your value (and influence your CEO) 🤔 all at the Architecture of HVC @hvpaa https://t.co/GmyI7LJm7Q @HopkinsMedicine